Acumentis CEO Herspiegel steps down as Burden assumes role

pharmafile | October 27, 2026 | Appointment | |  Appointments Corporate, Corporate 

Ramil Burden is the new Chief Executive Officer of Acumetis, announced the company in a recent statement. 

Founder and CEO Brent Herspiegel will retire from the CEO role and continue serving on the company’s Board of Directors, helping ensure a seamless transition and supporting the company’s long-term success.

Related Content

No items found
The Gateway to Local Adoption Series

Latest content